Bristol-Myers Squibb (United Kingdom)

Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models

Tim Reason, Emma Benbow, Julia Langham et al.

2024 · 55 Zit.

Unintended consequences of machine learning in medicine?

Laura McDonald, Sreeram V Ramagopalan, Andrew Cox et al.

2017 · 35 Zit.

Artificial Intelligence to Automate Health Economic Modelling: A Case Study to Evaluate the Potential Application of Large Language Models

Tim Reason, William D. Rawlinson, Julia Langham et al.

2024 · 25 Zit.

P46 Can Large Language Models Simulate HTA Committee Discussions? Findings and Challenges from a Case Study in Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer

T. Reason, S. Klijn, A. Gimblett et al.

2024 · 1 Zit.

MSR80 AI-Enabled Risk of Bias Assessment of RCTs in Systematic Reviews: A Case Study

Julia Langham, T. Reason, Bill Malcolm et al.

2023 · 1 Zit.

Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchers

Kevin G. Pollock, Carissa Dickerson, Manjit Kainth et al.

2024 · 1 Zit.

MSR24 AI-Driven Simulation of FDA DCOA Review to Inform Evidence Planning and Regulatory Strategy

Rajdeep Kaur, Sarah M. Donelson, Matthew A. Dixon et al.

2025 · 0 Zit.

282P Impact of artificial intelligence (AI) on follow-up of incidental lung nodules: A US multi-center ambispective study

Jasleen Pannu, N. S. Hill, M. Viseroi et al.

2025 · 0 Zit.